Bilirubin comes from the breakdown of hemoglobin.
Bilirubin comes from the breakdown of hemoglobin. Before passing through the liver it is indirect, or unconjugated; after conjugation, direct. Knowing which of the two predominates divides the causes into two completely different groups. Clinical jaundice appears from about 2.5–3 mg/dL (about 43–51 µmol/L).
Next: AST and ALT · INR and prothrombin time · Hemoglobin
Accelerated destruction of red cells generates more bilirubin than the liver can conjugate. It comes with high LDH, low haptoglobin and high reticulocytes.
A benign and common disorder, with a mild elevation that increases with fasting, stress or infections and with the rest of the liver profile normal. It requires no treatment.
Obstruction of the bile duct by stones or tumor, with raised alkaline phosphatase and GGT, dark urine and pale stools.
Hepatitis of any cause and advanced cirrhosis, with raised transaminases.
Low bilirubin values have no diagnostic relevance.
The first step is to separate direct from indirect. With indirect predominance, hemolysis is studied and Gilbert syndrome is considered; with direct predominance, it is assessed whether the pattern is cholestatic (high alkaline phosphatase and GGT) or hepatocellular (high transaminases), and the bile duct is examined.
Indirect is the one that has not yet passed through the liver, and it rises in hemolysis and in Gilbert syndrome. Direct is already conjugated, and its elevation points to cholestasis or hepatocellular damage. Separating them is the first step of the work-up.
The yellow color of skin and mucous membranes becomes visible from approximately 2.5 to 3 mg/dL, being seen earlier in the conjunctiva than in the skin.
This page is educational material for medical training: it describes the clinical meaning of the test and the causes of its abnormalities. It is not a diagnosis or a treatment recommendation, and it does not replace the laboratory report or the individual clinical assessment, which interprets each result in its context.